Search

everythinglearnresearchcommunity

for

Search:↓

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Effective treatments for severe alopecia areata are still lacking.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Adalimumab helped control a child's severe eye disease when other treatments failed.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Niosomes are a promising and effective way to deliver drugs through the skin.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

New treatments for lupus show promise, but more research is needed, especially for children.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Some cancer treatments can cause permanent hair loss.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Minoxidil slows down keratinocyte growth without being toxic.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.